Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment with OxyPR with regards to analgesic efficacy and locomotor function as assessed by the Western Ontario and McMaster Universities Osteoarthritis Composite Index (WOMAC VA3.1, visual analogue scale) in subjects with moderate to severe OA pain. • To demonstrate that subjects with moderate to severe OA pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation as measured by the bowel function index (BFI) compared to subjects taking oxycodone prolonged release tablets alone.
Inclusion criteria
- Pain, locomotor function and improvement in constipation in osteoarthritis patients taking opioids